Cargando…

Home blood pressure monitoring: Australian Expert Consensus Statement

Measurement of blood pressure (BP) by a doctor in the clinic has limitations that may result in an unrepresentative measure of underlying BP which can impact on the appropriate assessment and management of high BP. Home BP monitoring is the self-measurement of BP in the home setting (usually in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharman, James E., Howes, Faline S., Head, Geoffrey A., McGrath, Barry P., Stowasser, Michael, Schlaich, Markus, Glasziou, Paul, Nelson, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671913/
https://www.ncbi.nlm.nih.gov/pubmed/26136205
http://dx.doi.org/10.1097/HJH.0000000000000673
_version_ 1782404466718277632
author Sharman, James E.
Howes, Faline S.
Head, Geoffrey A.
McGrath, Barry P.
Stowasser, Michael
Schlaich, Markus
Glasziou, Paul
Nelson, Mark R.
author_facet Sharman, James E.
Howes, Faline S.
Head, Geoffrey A.
McGrath, Barry P.
Stowasser, Michael
Schlaich, Markus
Glasziou, Paul
Nelson, Mark R.
author_sort Sharman, James E.
collection PubMed
description Measurement of blood pressure (BP) by a doctor in the clinic has limitations that may result in an unrepresentative measure of underlying BP which can impact on the appropriate assessment and management of high BP. Home BP monitoring is the self-measurement of BP in the home setting (usually in the morning and evening) over a defined period (e.g. 7 days) under the direction of a healthcare provider. When it may not be feasible to measure 24-h ambulatory BP, home BP may be offered as a method to diagnose and manage patients with high BP. Home BP has good reproducibility, is well tolerated, is relatively inexpensive and is superior to clinic BP for prognosis of cardiovascular morbidity and mortality. Home BP can be used in combination with clinic BP to identify ‘white coat’ and ‘masked’ hypertension. An average home BP of at least 135/85 mmHg is an appropriate threshold for the diagnosis of hypertension. Home BP may also offer the advantage of empowering patients with their BP management, with benefits including increased adherence to therapy and lower achieved BP levels. It is recommended that, when feasible, home BP should be considered for routine use in the clinical management of hypertension.
format Online
Article
Text
id pubmed-4671913
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-46719132015-12-09 Home blood pressure monitoring: Australian Expert Consensus Statement Sharman, James E. Howes, Faline S. Head, Geoffrey A. McGrath, Barry P. Stowasser, Michael Schlaich, Markus Glasziou, Paul Nelson, Mark R. J Hypertens Consensus Document Measurement of blood pressure (BP) by a doctor in the clinic has limitations that may result in an unrepresentative measure of underlying BP which can impact on the appropriate assessment and management of high BP. Home BP monitoring is the self-measurement of BP in the home setting (usually in the morning and evening) over a defined period (e.g. 7 days) under the direction of a healthcare provider. When it may not be feasible to measure 24-h ambulatory BP, home BP may be offered as a method to diagnose and manage patients with high BP. Home BP has good reproducibility, is well tolerated, is relatively inexpensive and is superior to clinic BP for prognosis of cardiovascular morbidity and mortality. Home BP can be used in combination with clinic BP to identify ‘white coat’ and ‘masked’ hypertension. An average home BP of at least 135/85 mmHg is an appropriate threshold for the diagnosis of hypertension. Home BP may also offer the advantage of empowering patients with their BP management, with benefits including increased adherence to therapy and lower achieved BP levels. It is recommended that, when feasible, home BP should be considered for routine use in the clinical management of hypertension. Lippincott Williams & Wilkins 2015-09 2015-08-12 /pmc/articles/PMC4671913/ /pubmed/26136205 http://dx.doi.org/10.1097/HJH.0000000000000673 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
spellingShingle Consensus Document
Sharman, James E.
Howes, Faline S.
Head, Geoffrey A.
McGrath, Barry P.
Stowasser, Michael
Schlaich, Markus
Glasziou, Paul
Nelson, Mark R.
Home blood pressure monitoring: Australian Expert Consensus Statement
title Home blood pressure monitoring: Australian Expert Consensus Statement
title_full Home blood pressure monitoring: Australian Expert Consensus Statement
title_fullStr Home blood pressure monitoring: Australian Expert Consensus Statement
title_full_unstemmed Home blood pressure monitoring: Australian Expert Consensus Statement
title_short Home blood pressure monitoring: Australian Expert Consensus Statement
title_sort home blood pressure monitoring: australian expert consensus statement
topic Consensus Document
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671913/
https://www.ncbi.nlm.nih.gov/pubmed/26136205
http://dx.doi.org/10.1097/HJH.0000000000000673
work_keys_str_mv AT sharmanjamese homebloodpressuremonitoringaustralianexpertconsensusstatement
AT howesfalines homebloodpressuremonitoringaustralianexpertconsensusstatement
AT headgeoffreya homebloodpressuremonitoringaustralianexpertconsensusstatement
AT mcgrathbarryp homebloodpressuremonitoringaustralianexpertconsensusstatement
AT stowassermichael homebloodpressuremonitoringaustralianexpertconsensusstatement
AT schlaichmarkus homebloodpressuremonitoringaustralianexpertconsensusstatement
AT glaszioupaul homebloodpressuremonitoringaustralianexpertconsensusstatement
AT nelsonmarkr homebloodpressuremonitoringaustralianexpertconsensusstatement